• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

吸烟:一种慢性病?

Tobacco use: a chronic illness?

机构信息

Department of Preventive Medicine and Environmental Health, University of Kentucky College of Public Health, 121 Washington Avenue, Lexington, KY 40536, USA.

出版信息

J Community Health. 2010 Oct;35(5):549-53. doi: 10.1007/s10900-010-9241-x.

DOI:10.1007/s10900-010-9241-x
PMID:20177752
Abstract

Tobacco use is a modifiable risk factor that has many characteristics of a chronic illness. We analyzed longitudinal data from participants in the Atherosclerosis Risk in Communities Study (ARIC) and the Cardiovascular Health Study (CHS) and compared tobacco use to other chronic illnesses to evaluate effects on mortality. We limited our analysis to 20,293 participants aged 45 and older at baseline. We determined smoking status, diabetes status, hypertension, cardiovascular disease (ASCVD), and lung disease status at baseline. We developed Cox proportional hazard models, adjusting for age, sex and race and all comorbid diseases, to determine the effect of disease on mortality at up to 13 years of follow-up, 3,022 study participants died during the follow-up period. Adjusted proportional hazard models found that the risk of smoking for death had a hazard ratio (HR) of 2.0 (95% confidence interval [CI] 1.8, 2.2). This was similar to the mortality risk for ASCVD (HR 1.8, 95% CI 1.7, 2.0), diabetes (HR 1.9, 95% CI 1.7, 2.0), and chronic obstructive pulmonary disease (COPD) (HR 2.1, 95% CI 1.9, 2.4). The risk in former smokers were significantly less than that of current smokers (HR 1.1, 95% CI 1.01, 1.2). In the adjusted models, current cigarette smoking has a mortality risk that is in the same range of that seen in other "chronic diseases", whereas the risk in former smokers is greatly reduced. These data suggest that current smoking should be approached as aggressively as other chronic diseases that are amenable to interventions.

摘要

吸烟是一种可改变的风险因素,具有许多慢性疾病的特征。我们分析了动脉粥样硬化风险社区研究(ARIC)和心血管健康研究(CHS)参与者的纵向数据,并将吸烟与其他慢性疾病进行了比较,以评估对死亡率的影响。我们将分析限于基线时年龄在 45 岁及以上的 20293 名参与者。我们确定了基线时的吸烟状况、糖尿病状况、高血压、心血管疾病(ASCVD)和肺部疾病状况。我们开发了 Cox 比例风险模型,根据年龄、性别和种族以及所有合并疾病进行调整,以确定疾病在长达 13 年的随访期间对死亡率的影响,在随访期间,有 3022 名研究参与者死亡。调整后的比例风险模型发现,吸烟导致死亡的风险比(HR)为 2.0(95%置信区间 [CI] 1.8,2.2)。这与 ASCVD(HR 1.8,95%CI 1.7,2.0)、糖尿病(HR 1.9,95%CI 1.7,2.0)和慢性阻塞性肺疾病(COPD)(HR 2.1,95%CI 1.9,2.4)的死亡率风险相似。前吸烟者的风险明显低于当前吸烟者(HR 1.1,95%CI 1.01,1.2)。在调整后的模型中,当前吸烟导致的死亡率风险与其他“慢性疾病”所见的风险范围相当,而前吸烟者的风险大大降低。这些数据表明,应像干预其他可治疗的慢性疾病一样积极对待当前吸烟。

相似文献

1
Tobacco use: a chronic illness?吸烟:一种慢性病?
J Community Health. 2010 Oct;35(5):549-53. doi: 10.1007/s10900-010-9241-x.
2
Association of Cigarette, Cigar, and Pipe Use With Mortality Risk in the US Population.美国人群中香烟、雪茄和烟斗使用与死亡率风险的关联。
JAMA Intern Med. 2018 Apr 1;178(4):469-476. doi: 10.1001/jamainternmed.2017.8625.
3
Tobacco-related disease mortality among men who switched from cigarettes to spit tobacco.从吸卷烟改为吸嚼烟的男性中与烟草相关的疾病死亡率。
Tob Control. 2007 Feb;16(1):22-8. doi: 10.1136/tc.2006.018069.
4
Chronic obstructive pulmonary disease and hospitalizations for pneumonia in a US cohort.美国队列中的慢性阻塞性肺疾病与肺炎住院情况
Respir Med. 2009 Feb;103(2):224-9. doi: 10.1016/j.rmed.2008.09.005. Epub 2008 Oct 21.
5
Life expectancy and years of life lost in chronic obstructive pulmonary disease: findings from the NHANES III Follow-up Study.慢性阻塞性肺疾病患者的预期寿命和寿命损失年数:来自 NHANES III 随访研究的结果。
Int J Chron Obstruct Pulmon Dis. 2009;4:137-48. doi: 10.2147/copd.s5237. Epub 2009 Apr 15.
6
Smoking and mortality in a prospective cohort study of elderly Chinese in Hong Kong.香港老年华人前瞻性队列研究中的吸烟与死亡率。
Addiction. 2015 Mar;110(3):502-10. doi: 10.1111/add.12776. Epub 2014 Nov 26.
7
Chronic obstructive pulmonary disease as an independent risk factor for cardiovascular morbidity.慢性阻塞性肺疾病作为心血管发病风险的独立危险因素。
Int J Chron Obstruct Pulmon Dis. 2009;4:337-49. doi: 10.2147/copd.s6400. Epub 2009 Sep 24.
8
Association of Long-term, Low-Intensity Smoking With All-Cause and Cause-Specific Mortality in the National Institutes of Health-AARP Diet and Health Study.美国国立卫生研究院-美国退休人员协会饮食与健康研究中,长期低强度吸烟与全因死亡率及特定病因死亡率的关联。
JAMA Intern Med. 2017 Jan 1;177(1):87-95. doi: 10.1001/jamainternmed.2016.7511.
9
All-cause mortality and risk factors in a cohort of retired military male veterans, Xi'an, China: an 18-year follow up study.中国西安退休男性退伍军人队列中的全因死亡率及危险因素:一项18年随访研究
BMC Public Health. 2007 Oct 12;7:290. doi: 10.1186/1471-2458-7-290.
10
Mortality among male smokers and smokeless tobacco users in the USA.美国男性烟民和无烟烟草使用者的死亡率。
Harm Reduct J. 2019 Aug 20;16(1):50. doi: 10.1186/s12954-019-0321-7.

引用本文的文献

1
Addressing Smoking Cessation among Women in Substance Use Treatment: A Qualitative Approach to Guiding Tailored Interventions.解决物质使用治疗中女性的戒烟问题:一种指导量身定制干预措施的定性方法。
Int J Environ Res Public Health. 2021 May 27;18(11):5764. doi: 10.3390/ijerph18115764.
2
α7-Nicotinic Acetylcholine Receptor Agonist Ameliorates Nicotine Plus High-Fat Diet-Induced Hepatic Steatosis in Male Mice by Inhibiting Oxidative Stress and Stimulating AMPK Signaling.α7-烟碱型乙酰胆碱受体激动剂通过抑制氧化应激和刺激AMPK信号通路改善尼古丁加高脂饮食诱导的雄性小鼠肝脂肪变性
Endocrinology. 2018 Feb 1;159(2):931-944. doi: 10.1210/en.2017-00594.
3

本文引用的文献

1
Smoking cessation a critical component of medical management in chronic disease populations.戒烟是慢性病患者医疗管理的关键组成部分。
Am J Prev Med. 2007 Dec;33(6 Suppl):S414-22. doi: 10.1016/j.amepre.2007.09.013.
2
Factors associated with successful smoking cessation in the United States, 2000.2000年美国与成功戒烟相关的因素。
Am J Public Health. 2007 Aug;97(8):1503-9. doi: 10.2105/AJPH.2005.083527. Epub 2007 Jun 28.
3
Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary.
Tobacco Use Disorder Among Patients With Smoking-related Chronic Medical Disease: Association With Comorbid Substance Use Disorders.
吸烟相关慢性疾病患者中的烟草使用障碍:与共病物质使用障碍的关联。
J Addict Med. 2017 Jul/Aug;11(4):293-299. doi: 10.1097/ADM.0000000000000311.
4
Connection of Nicotine to Diet-Induced Obesity and Non-Alcoholic Fatty Liver Disease: Cellular and Mechanistic Insights.尼古丁与饮食诱导的肥胖及非酒精性脂肪性肝病的关联:细胞及机制方面的见解
Front Endocrinol (Lausanne). 2017 Feb 10;8:23. doi: 10.3389/fendo.2017.00023. eCollection 2017.
5
System change interventions for smoking cessation.戒烟的系统变革干预措施。
Cochrane Database Syst Rev. 2017 Feb 10;2(2):CD010742. doi: 10.1002/14651858.CD010742.pub2.
6
Nicotine plus a high-fat diet triggers cardiomyocyte apoptosis.尼古丁加高脂饮食会引发心肌细胞凋亡。
Cell Tissue Res. 2017 Apr;368(1):159-170. doi: 10.1007/s00441-016-2536-1. Epub 2016 Dec 5.
7
Additive effects of nicotine and high-fat diet on hepatocellular apoptosis in mice: involvement of caspase 2 and inducible nitric oxide synthase-mediated intrinsic pathway signaling.尼古丁与高脂饮食对小鼠肝细胞凋亡的相加作用:半胱天冬酶2及诱导型一氧化氮合酶介导的内源性途径信号传导的参与
Horm Metab Res. 2014 Jul;46(8):568-73. doi: 10.1055/s-0034-1375610. Epub 2014 May 15.
8
Nicotine in combination with a high-fat diet causes intramyocellular mitochondrial abnormalities in male mice.尼古丁与高脂肪饮食结合会导致雄性小鼠肌内线粒体异常。
Endocrinology. 2014 Mar;155(3):865-72. doi: 10.1210/en.2013-1795. Epub 2014 Jan 1.
9
Additive effects of nicotine and high-fat diet on hepatic steatosis in male mice.尼古丁和高脂肪饮食对雄性小鼠肝脂肪变性的累加作用。
Endocrinology. 2012 Dec;153(12):5809-20. doi: 10.1210/en.2012-1750. Epub 2012 Oct 23.
10
Impact of cigarette smoking on onset of nonalcoholic fatty liver disease over a 10-year period.吸烟对 10 年内非酒精性脂肪性肝病发病的影响。
J Gastroenterol. 2011 Jun;46(6):769-78. doi: 10.1007/s00535-011-0376-z. Epub 2011 Feb 8.
慢性阻塞性肺疾病诊断、管理和预防全球策略:GOLD执行摘要
Am J Respir Crit Care Med. 2007 Sep 15;176(6):532-55. doi: 10.1164/rccm.200703-456SO. Epub 2007 May 16.
4
Risk factors for cardiovascular event recurrence in the Atherosclerosis Risk in Communities (ARIC) study.社区动脉粥样硬化风险(ARIC)研究中心血管事件复发的危险因素。
Am Heart J. 2005 Apr;149(4):606-12. doi: 10.1016/j.ahj.2004.07.019.
5
Impaired lung function and subclinical atherosclerosis. The ARIC Study.
Atherosclerosis. 2005 Jun;180(2):367-73. doi: 10.1016/j.atherosclerosis.2004.12.012. Epub 2005 Jan 25.
6
Global Initiative on Obstructive Lung Disease (GOLD) classification of lung disease and mortality: findings from the Atherosclerosis Risk in Communities (ARIC) study.慢性阻塞性肺疾病全球倡议(GOLD)对肺部疾病的分类与死亡率:社区动脉粥样硬化风险(ARIC)研究的结果
Respir Med. 2006 Jan;100(1):115-22. doi: 10.1016/j.rmed.2005.03.035.
7
Comorbidity of chronic diseases: effects of disease pairs on physical and mental functioning.慢性病共病:疾病配对对身体和心理功能的影响。
Qual Life Res. 2005 Feb;14(1):45-55. doi: 10.1007/s11136-004-0616-2.
8
The effects of a smoking cessation intervention on 14.5-year mortality: a randomized clinical trial.戒烟干预对14.5年死亡率的影响:一项随机临床试验。
Ann Intern Med. 2005 Feb 15;142(4):233-9. doi: 10.7326/0003-4819-142-4-200502150-00005.
9
Indicators for chronic disease surveillance.慢性病监测指标。
MMWR Recomm Rep. 2004 Sep 10;53(RR-11):1-6.
10
Preventing 3 million premature deaths and helping 5 million smokers quit: a national action plan for tobacco cessation.预防300万人过早死亡并帮助500万吸烟者戒烟:一项国家戒烟行动计划。
Am J Public Health. 2004 Feb;94(2):205-10. doi: 10.2105/ajph.94.2.205.